210
Participants
Start Date
June 28, 2017
Primary Completion Date
August 31, 2019
Study Completion Date
August 31, 2019
Emricasan (25 mg)
25 mg emricasan
Emricasan (5 mg)
5 mg emricasan
Placebo
Matching Placebo
NYU Medical Center, New York
Weill Cornell Medical College, New York
Columbia University Medical Center - Center for Liver Disease and Transplantation, New York
Northwell Health Inc., Sandra Atlas Bass Center for Liver Diseases., Manhasset
University of Rochester Medical Center, Rochester
Hospital of the University of Pennsylvania, Philadelphia
Emeritas Research Group LLC, Leesburg
Walter Reed National Military Medical Center (WRNMMC), Bethesda
Mercy Medical Center, Baltimore
Digestive Disease Associates, PA, Catonsville
University of Virginia, Charlottesville
Bon Secours Liver Institute of Virginia, Richmond
Virginia Commonwealth University, Richmond
Banner University Medical Center - Phoenix Transplant Institute, Newport News
Duke University Medical Center, Durham
Carolinas Healthcare System, Center for Liver Disease, Charlotte
Diabetes & Endocrinology Consultants, PC, Morehead City
Medical University of South Carolina, Charleston
GHS Gastroenterology and Liver Center, Greenville
Gastrointestinal Specialists of Georgia, Marietta
Piedmont Transplant Institute, Atlanta
Mayo Clinic, Jacksonville
UF Hepatology Research at CTRB, Gainesville
Florida Hospital Transplant Institute, Orlando
Schiff Center for Liver Disease/University of Miami, Miami
IMIC Inc., Palmetto Bay
Tampa General Hospital, Tampa
Florida Research Institute, Lakewood Rch
Vanderbilt University Medical Center, Nashville
ClinSearch, LLC, Chattanooga
University of Mississippi Medical Center, Division of Digestive Diseases, Jackson
UC Health/ UCPC LLC, Cincinnati
Indiana University, Indianapolis
Aquiant Research, Albany
Henry Ford Health System, Detroit
University of Iowa Hospitals and Clinics/ Internal Medicine, Iowa City
Mayo Clinic, Rochester
Northwestern University, Chicago
Rush University Medical Center, Chicago
Kansas City Research Institute, Kansas City
Ochsner Clinic Foundation, New Orleans
Delta Research Partners, Bastrop
Options Health Research, LLC, Tulsa
Methodist Health System Clinical Research Institute, Dallas
University of Texas Southwestern Medical Center, Dallas
Texas Clinical Research Institute, Arlington
Baylor Scott & White Research Institute, Fort Worth
Baylor College of Medicine - Advanced Liver Therapies, Houston
Liver Associates of Texas, P.A., Houston
American Research Corporation at the Texas Liver Institue, San Antonio
Methodist Specialty & Transplant Hospital, San Antonio
San Antonio Military Medical Center, San Antonio
University of Colorado Denver, Aurora
Peak Enterology Associates, Colorado Springs
University of Utah, Salt Lake City
St. Joseph's Hospital & Medical Center, Phoenix
Mayo Clinic Arizona, Phoenix
The Institute for Liver Health, Chandler
University of Arizona Liver Research Institute, Tucson
Cedars Sinai Medical Center, Los Angeles
UCLA Pfleger Liver Institute, Los Angeles
California Liver Research Institute, Pasadena
Scripps Clinic - Torrey Pines, San Diego
Inland Empire Liver Foundation, Rialto
University of California, San Francisco-Fresno, Fresno
Stanford University, Redwood City
California Pacific Medical Center, San Francisco
University of California San Francisco, San Francisco
UC Davis GI/Hepatology Clinical Trials Unit, Sacramento
Swedish Organ Transplant and Liver Center, Seattle
University of Washington Harborview Medical Center, Seattle
University of Washington, Seattle
West Haven VA Medical Center, West Haven
Massachusetts General Hospital, Boston
Beth Israel Deaconess Medical Center, Boston
Rutgers New Jersey Medical School, Newark
Lead Sponsor
Conatus Pharmaceuticals Inc.
INDUSTRY